TWi Biotechnology, Inc. (6610.TWO)
TWD 9.57
(-19.58%)
TWD 9.57
(-19.58%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 396.85 Million TWD | 69.37% |
| 2022 | 234.31 Million TWD | -24.67% |
| 2021 | 311.04 Million TWD | -19.64% |
| 2020 | 387.03 Million TWD | -9.8% |
| 2019 | 429.1 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 299.87 Million TWD | 0.0% |
| 2024 Q1 | 299.87 Million TWD | -24.44% |
| 2023 Q1 | 191.09 Million TWD | -18.44% |
| 2023 Q2 | 191.09 Million TWD | 0.0% |
| 2023 FY | 396.85 Million TWD | 69.37% |
| 2023 Q4 | 396.85 Million TWD | 0.0% |
| 2023 Q3 | 396.85 Million TWD | 107.67% |
| 2022 Q3 | 234.31 Million TWD | 0.0% |
| 2022 Q4 | 234.31 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -209.926% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 86.32% |
| Level Biotechnology Inc. | 822.67 Million TWD | 51.761% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 40.298% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 27.681% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 89.808% |
| GlycoNex Incorporation | 1.55 Billion TWD | 74.443% |
| VBI | 452.1 Million TWD | 12.221% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 66.258% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 46.986% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -4.887% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 65.0% |
| Visgeneer Inc. | 397.17 Million TWD | 0.082% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 89.475% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 81.619% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 55.061% |
| Neith Corporation | 192.15 Million TWD | -106.529% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 93.486% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -439.508% |
| Enimmune corporation | 604.82 Million TWD | 34.386% |
| TaiRx, Inc. | 833.74 Million TWD | 52.401% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 87.14% |
| EirGenix Inc. | 11.16 Billion TWD | 96.445% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 30.758% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 76.824% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 88.966% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 62.222% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -31.83% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -49.949% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 10.05% |
| RBC Bioscience Corporation | 753.79 Million TWD | 47.353% |
| BiOptic Inc. | 613.77 Million TWD | 35.342% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 77.688% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 65.78% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 38.458% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 87.224% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -168.262% |
| NaviFUS Corp. | 490.53 Million TWD | 19.098% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 67.623% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 70.892% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 25.002% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 65.83% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 76.04% |
| AP Biosciences Inc | 890.75 Million TWD | 55.448% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 95.346% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -22.429% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 70.243% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 85.362% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 97.417% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 3.268% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 80.883% |
| TCI GENE Inc. | 1.16 Billion TWD | 65.963% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -34.717% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 70.891% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 57.861% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 43.181% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 89.963% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 89.618% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 67.731% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 92.918% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 62.632% |
| Acepodia, Inc. | 6.81 Billion TWD | 94.18% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 89.629% |